Author:
Hsiung Chien-Ya,Chen Hsin-Yu,Wang Shih-Han,Huang Ching-Ying
Abstract
De novo thrombotic microangiopathy (TMA) is a rare and challenging condition in kidney transplant recipients, with limited research on its incidence and impact on graft survival. This study conducted a systematic review and meta-analysis of 28 cohorts/single-arm studies and 46 case series/reports from database inception to June 2022. In meta-analysis, among 14,410 kidney allograft recipients, de novo TMA occurred in 3.20% [95% confidence interval (CI): 1.93–4.77], with systemic and renal-limited TMA rates of 1.38% (95% CI: 06.5–2.39) and 2.80% (95% CI: 1.27–4.91), respectively. The overall graft loss rate of de novo TMA was 33.79% (95% CI: 26.14–41.88) in meta-analysis. This study provides valuable insights into the incidence and graft outcomes of de novo TMA in kidney transplant recipients.
Reference65 articles.
1. Atypical Hemolytic Uremic Syndrome (aHUS): Essential Aspects of an Accurate Diagnosis;Laurence;Clin Adv Hematol Oncol,2016
2. An Acute Febrile Pleiochromic Anemia With Hyaline Thrombosis of the Terminal Arterioles and Capillaries: An Undescribed Disease;Moschcowitz;Mt Sinai J Med,1925
3. Thrombotic Microangiopathy After Renal Transplantation in the United States;Reynolds;Am J Kidney Dis,2003
4. De Novo Thrombotic Microangiopathy in Renal Transplant Recipients: A Comparison of Hemolytic Uremic Syndrome With Localized Renal Thrombotic Microangiopathy;Schwimmer;Am J Kidney Dis,2003
5. De Novo Thrombotic Microangiopathy in Two Kidney Transplant Recipients From the Same Deceased Donor: A Case Series;Roberts;Clin Transpl,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献